MURPHY JAMES G 4

Accession 0001209191-13-014344

CIK 0001138400other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:43 PM ET

Size

25.4 KB

Accession

0001209191-13-014344

Form 4

Period: 2013-03-01

Director

Transactions

Disposition to Issuer
Common Stock
2013-03-01−56,964→ 0 total
Exercise/Conversion
Stock Options (right to buy)
2013-03-01−20,000→ 0 total
Exercise: $2.63Exp: 2022-06-11→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Options (right to buy)
2013-03-01−10,653→ 0 total
Exercise: $9.95Exp: 2019-06-18→ Common Stock (10,653 underlying)
Disposition to Issuer
Stock Options (right to buy)
2013-03-01−5,831→ 0 total
Exercise: $17.09Exp: 2017-06-21→ Common Stock (5,831 underlying)
Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,538→ 0 total
Exercise: $12.66Exp: 2020-06-17→ Common Stock (8,538 underlying)
Exercise/Conversion
Common Stock
2013-03-01$5.80/sh+18,736$108,669→ 36,964 total
Exercise/Conversion
Stock Options (right to buy)
2013-03-01−18,736→ 0 total
Exercise: $5.80Exp: 2021-06-14→ Common Stock (18,736 underlying)
Exercise/Conversion
Common Stock
2013-03-01$2.63/sh+20,000$52,600→ 56,964 total
Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,840→ 0 total
Exercise: $11.64Exp: 2018-06-19→ Common Stock (8,840 underlying)

Footnotes (6)

[F1]Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright.
[F2]Option exercised. Pursuant to the Merger Agreement, this stock option was conditionally vested to 100% subject to exercise upon the merger transaction. The reporting person received merger consideration described in footnote (1) above.
[F3]Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00.
[F4]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share.
[F5]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,559 shares of Wright common stock at an exercise price of $19.07 per share.
[F6]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,455 shares of Wright common stock at an exercise price of $24.26 per share.

Documents

2 files

BIOMIMETIC THERAPEUTICS, INC.

CIK 0001138400

Entity typeother